Tumori Journal

Papers
(The median citation count of Tumori Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone approval56
Impact of the STK11/KRAS co-mutation on the response to immunotherapy in a real-world pan-cancer cohort43
Effect of body mass index on immune checkpoint inhibitor efficacy in patients with advanced cancer32
Stereotactic body radiotherapy in oligoprogressive metastatic castration-resistant prostate cancer during abiraterone or enzalutamide31
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis16
Outcomes of first-line chemo-immunotherapy in advanced non-squamous NSCLC according to KRAS status: An Italian real-world study13
Fertility and abortion: A population-based comparison between women with cancer and those in childbearing age11
Oral vinorelbine in young patients with desmoid-type fibromatosis10
Chemo-surgical approach in vulvar leiomyosarcoma: A case report10
Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer10
Blooming in the rain9
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients8
Ongoing discussion: Is prophylactic central neck dissection necessary in c T 1a-b,2 N 8
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach8
The impact of bio-psycho-social factors on mental health outcomes in patients with solid tumors8
Time trends of cancer incidence in young adults (20-49 years) in Italy. A population - based study, 2008-20177
Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma7
Emerging therapeutic strategies in Lynch syndrome-associated colorectal cancer and the role of MMR testing7
Enhanced patient journey associated with improved overall survival in colon cancer patients: A study by the Ligurian Oncology Network7
Synergistic effects of XPO1 inhibitors combined with CD19 CAR-T cells in TP53-mutated DLBCL6
Prognostic value of Aurora B expression in cancer patients: A meta-analysis6
ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma6
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients6
Humanistic nursing combined with Neuman’s nursing in the application for oncology patients6
Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes6
Advances in spatial multi-omics in tumors6
Expression of concern6
Quality assurance for cancer patient safety: Clinical assessment for precise angles in linac during radiation therapy5
Outcomes of chemotherapy/chemoradiation vs. R2 surgical debulking vs. palliative care in nonresectable locally recurrent rectal cancer5
Nutritional status as a risk factor for adverse events associated with L-Asparaginase in children with acute lymphoblastic leukemia5
Periprosthetic effusions surrounding breast expander: a flow cytometric, immunohistochemical and molecular characterization5
Survey among childhood cancer survivors about their preferences on functionalities of a to-be-developed Survivorship Passport Mobile App5
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects5
Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I–III NSCLC5
MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?4
Hippocampal region avoidance in whole brain radiotherapy in brain metastases: For all or for some? A real-world feasibility report4
KRAS inhibitors in drug resistance and potential for combination therapy4
15th BGICC Abstract Book 20234
Breast cancer and large-cell neuroendocrine carcinoma harboring the same PIK3CA mutation: A case report4
Personalized treatment using predictive biomarkers in solid organ malignancies: A review4
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes4
Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study4
Italian oncologists and vaccinations against infectious diseases: Results of a survey of the Italian Association of Medical Oncology4
Ethics in the evaluation of the quality of scientific research: An AIOM-TJ roundtable4
Corrigendum to: AIRO Breast Cancer Group Best Clinical Practice 2022 Update4
Secular trends in incidence and mortality of non-Hodgkin’s lymphoma in China, 1990–2019, and predictions to 2030: Outlook for the future burden of disease4
Current practices of follow-up programs for childhood cancer survivors in Italy4
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation3
Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience3
End-of-Life transfusion support at hospice and pediatric oncology unit: Bridging the gap between benefits and therapeutic alliance3
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making3
The digital revolution in pathology: Towards a smarter approach to research and treatment3
Quality of life and sexual function after breast conservation surgery and mastectomy without reconstruction in South Indian patients3
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice3
Generative AI and medical oncologists: Be curious, but cautious!3
Efficacy and safety of PD-1 inhibitor plus chemotherapy in advanced nasopharyngeal carcinoma: A meta-analysis3
I was only sixteen3
Advancing biomarker development for diagnostics and therapeutics using solid tumour cancer stem cell models3
A phase II study of nivolumab plus metformin in pre-treated metastatic renal cell carcinoma patients: NivoMet TWINS-GU002 Study3
Precision animal models of tumors: Advances, challenges and clinical translation3
Immunogenicity of radiotherapy on bone metastases from prostate adenocarcinoma: What is the future for the combination with radiotherapy/immunotherapy?3
AIOM Abstract3
Italian translation, cultural adaptation and pilot testing of Psychosocial Assessment Tool (PAT 3.1) in pediatric cancer3
A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy3
Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosis3
The impact of body mass index on the treatment response to neoadjuvant chemotherapy in patients with breast cancer: A systematic review and meta-analysis3
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting2
Breast implant associated anaplastic large cell lymphoma: Evidence for an efficient diagnostic workup2
Increased expression of FGF14 and SCN2A/SCN11A is associated with better survival of HCC patients2
Implementation of a MSRE ddPCR method for the detection of methylated WIF1 and NPY genes in colorectal can2
Management of primary and recurrent Bartholin’s gland carcinoma: A systematic review on behalf of MITO Rare Cancer Group2
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund2
Corrigendum to “Self-perceived attitudes of Italian oncology nurses towards clinical trial involvement: A cohort observational study”2
Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments2
Associations between vascular endothelial growth factor polymorphisms and response to 5-FU-based pharmaceutical therapy in esophageal squamous cell carcinoma: A meta-analysis2
Pediatric palliative care in patients with brain tumors: Timing, activation, and management of acute events2
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridization2
De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?2
Central venous catheters-related-thrombosis and risk factors in oncological patients: A retrospective evaluation of recent risk scores2
Outcome of non-small-cell lung cancer with driven mutations treated with anti-PD-(L)1 agents: A systematic review2
ALYREF promotes laryngeal cancer progression through a lactate-mediated lactylation feedback loop that enhances glycolysis2
Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey2
18th BGIICC Abstract Book 20262
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study2
Digital workload in oncology trials: A comparative analysis of e-portal usage and operational insights from a single-center experience2
A shared vaccination ambulatory for patients with cancer in Udine, Italy2
Overview of combined adjuvant strategies for tumor biomarker detection2
Risk-based breast cancer screening: What are the challenges?2
Identification and selection of the best artificial intelligence methods developed for detection and diagnosis of breast cancer2
ERBB2 mutation landscape in non-small cell lung cancer patients in Northeast China2
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs2
Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data2
Factors influencing the colorectal surveillance adherence in Lynch Syndrome: A retrospective monocentric study2
Retroperitoneal lymph-node dissection (RPLND) as upfront management in stage II germ-cell tumours: Evaluation of safety and efficacy2
Adjuvant chemotherapy in elderly patients with HER2-negative early breast cancer: A systematic review and meta-analysis1
Electronic cigarette, or vaping, product use-associated lung injury (EVALI) in a patient with testicular cancer: A case report1
Forceful survivorship: The desire to procreate in parents of cancer patients1
A homogeneous treatment for non-DIPG diffuse midline glioma1
Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data1
Mind the gap with Europe. Why public interest cannot be a good reason to perform observational and epidemiological research?1
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey1
Prevalence of breast cancer in ovarian cancer patients and its impact on patient survival: An analysis of the surveillance, epidemiology, and end results data1
Modern approaches to target tumor heterogeneity: Integrating technology and treatment1
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching1
European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team1
The role of diet as adjuvant treatment in FAP patients1
Clinical difference between solitary and multiple pulmonary adenocarcinoma nodules1
Corrigendum to “Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure”1
Exploratory analysis of the professional quality of life in an Italian radiotherapy department: The role of empathy and alexithymia1
Delphi Study on the creation of a Committee of patients, caregivers, and representatives of patient associations1
Clinicopathological characteristics and prognosis of cervical adenocarcinoma across diverse histological subtypes1
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics Days1
Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey1
The e-BRAVE study: A prospective web-based cohort and biobank of women carriers of BRCA mutations1
The challenges of cascade genetic testing in hereditary cancer syndromes: A few ethical considerations1
Diagnostic and prognostic role of GPX1 in NK/T cell lymphoma1
Ten tips to reduce gaps in daily oncology practice1
The impact of the new European CTR on academic clinical research: A survey by the Italian Sarcoma Group Federated Trial Centre1
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936)1
Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study1
Get up, stand up: Alongside adolescents and young adults with cancer for their right to be forgotten1
The “empty speech bubbles”: Explaining cancer through play. A pediatric oncology unit pilot experience1
A five-year review of chemoradiotherapy practice in anal cancer: Radiotherapy audit results from a cancer centre in Wales, UK1
North-south differences in incidence and surveillance of cutaneous malignant melanoma in Italy1
Association between clinical factors and the choice of palliative care setting among cancer patients: A post-hoc analysis of a cohort study1
Demyelinating polyradiculoneuropathy during dabrafenib and trametinib treatment for metastatic melanoma: A case report1
Can Ki-67 predict radiotherapy response in neuroendocrine tumors? Retrospective analysis of a monocentric series of patients1
The evolution of cinematic language in portraying cancer1
The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers1
Effects of uniportal 3D video-assisted thoracic surgery lobectomy on postoperative pain and immune function in patients with NSCLC1
Comparison of breast cancer surgery cases in urban and rural areas: Clinical factors and patient-reported outcomes1
0.085568904876709